ClinVar Miner

Submissions for variant NM_001037.5(SCN1B):c.590C>T (p.Ala197Val)

gnomAD frequency: 0.00002  dbSNP: rs554201948
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 8
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
GeneDx RCV000171054 SCV000223618 uncertain significance not provided 2023-11-06 criteria provided, single submitter clinical testing Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant does not alter protein structure/function; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown.; This variant is associated with the following publications: (PMID: 28341588, 34038903, 34572065, 24324597, 34628405, 32192759, 29758173)
Invitae RCV000646745 SCV000768530 uncertain significance Brugada syndrome 5 2023-11-19 criteria provided, single submitter clinical testing The SCN1B gene has multiple clinically relevant transcripts. This variant occurs in alternate transcript NM_001037.5, and corresponds to NM_199037.3:c.*5160C>T in the primary transcript. This sequence change replaces alanine, which is neutral and non-polar, with valine, which is neutral and non-polar, at codon 197 of the SCN1B protein (p.Ala197Val). This variant is present in population databases (rs554201948, gnomAD 0.006%). This missense change has been observed in individual(s) with Brugada syndrome (PMID: 29758173, 32192759). Algorithms developed to predict the effect of variants on protein structure and function are not available or were not evaluated for this variant. Experimental studies have shown that this missense change affects SCN1B function (PMID: 32192759). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.
Ambry Genetics RCV002354422 SCV002653272 uncertain significance Cardiovascular phenotype 2023-10-27 criteria provided, single submitter clinical testing The p.A197V variant (also known as c.590C>T), located in coding exon 4 of the SCN1B gene, results from a C to T substitution at nucleotide position 590. The amino acid change results in alanine to valine at codon 197, an amino acid with similar properties. However, this change occurs in the last base pair of coding exon 4, which makes it likely to have some effect on normal mRNA splicing. This nucleotide position is highly conserved in available vertebrate species. This amino acid position is highly conserved in available vertebrate species. In silico splice site analysis predicts that this alteration may result in the creation or strengthening of a novel splice donor site. In addition, as a missense substitution this is predicted to be inconclusive by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear.
Fulgent Genetics, Fulgent Genetics RCV002478539 SCV002776891 uncertain significance Generalized epilepsy with febrile seizures plus, type 1; Brugada syndrome 5; Atrial fibrillation, familial, 13; Developmental and epileptic encephalopathy, 52 2021-08-23 criteria provided, single submitter clinical testing
PreventionGenetics, part of Exact Sciences RCV004535162 SCV004121275 uncertain significance SCN1B-related disorder 2022-09-15 criteria provided, single submitter clinical testing The SCN1B c.590C>T variant is predicted to result in the amino acid substitution p.Ala197Val. This variant was reported in two individuals with Brugada syndrome or cardiac arrest (Gray et al. 2018. PubMed ID: 29758173; Wang et al. 2020. PubMed ID: 32192759; Zhu et al. 2021. PubMed ID: 34628405). Functional studies suggested that this variant could impact normal protein function (Wang et al. 2020. PubMed ID: 32192759; Zhu et al. 2021. PubMed ID: 34628405). This variant is reported in 0.0062% of alleles in individuals of African descent in gnomAD (http://gnomad.broadinstitute.org/variant/19-35530162-C-T) and is interpreted as uncertain significance (https://www.ncbi.nlm.nih.gov/clinvar/variation/190874/). A different nucleotide substitution affecting the same amino acid (p.Ala197Asp) has been reported in an individual with Brugada syndrome (Ricci et al. 2014. PubMed ID: 25253298). At this time, the clinical significance of the c.590C>T (p.Ala197Val) variant is uncertain due to the absence of conclusive functional and genetic evidence.
CeGaT Center for Human Genetics Tuebingen RCV000171054 SCV004145415 uncertain significance not provided 2023-06-01 criteria provided, single submitter clinical testing SCN1B: PM5, PP3
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+ RCV000171054 SCV001953868 uncertain significance not provided no assertion criteria provided clinical testing
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000171054 SCV001975818 uncertain significance not provided no assertion criteria provided clinical testing

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.